NOAEL Data IARC Group 3 REACH Registered Cosmetic Ingredient

2-Nitro-1,4-phenylenediamine

Also known as: 2-Nitro-p-phenylenediamine, 3-13-00-00271, BRN 2210195, CI Oxidation Base 22, Durafur Brown (+12 more)

CAS 5307-14-2

2-Nitro-1,4-phenylenediamine (CAS 5307-14-2) is a chemical substance; key hazard signal: IARC Group 3. Key regulatory status: REACH registered, cosmetic ingredient cross-reference; source data from EPA ToxValDB, EPA CPDat, AICIS, IARC, ECHA REACH, ILO ICSC.

View cosmetic safety profile for 2-Nitro-P-Phenylenediamine →

SOURCE noael studies public
NOAEL studies
31
SOURCE chemical inventory jurisdictions
Regulatory lists
0
SOURCE eu clp annex vi
GHS signal
Not classified

Chemical Identity

CAS, identifiers, formula, and alternate names for the matched substance record.

SOURCE DSSTox identifiers 23 fields
Name
2-Nitro-1,4-phenylenediamine
CAS Number
5307-14-2
DTXSID
DTXSID4020957
Molecular Formula
C6H7N3O2
InChI Key
HVHNMNGARPCGGD-UHFFFAOYSA-N
Monoisotopic Mass
153.053826
Synonyms
2-Nitro-p-phenylenediamine3-13-00-00271BRN 2210195CI Oxidation Base 22Durafur BrownEINECS 226-164-5NCI-C022222-Nitrol-para-phenylenediamine2-Nitrol-p-phenylenediamineOxidation Base 221,4-DiaminonitrobenzolUNII-PV83F3C01Q

IARC Carcinogen Classification

Carcinogenic hazard classification from IARC monograph evaluations.

SOURCE IARC Monographs on the Identification of Carcinogenic Hazards to Humans 1 records
GroupMeaningEvaluatedVolume
Group 3Not classifiable1992Sup 7, 57

ICSC Chemical Safety

International Chemical Safety Card hazard and exposure summary.

SOURCE ILO/WHO International Chemical Safety Cards 1 records
FieldValue
Long-term EffectsRepeated or prolonged contact may cause skin sensitization.
Routes of ExposureThe substance can be absorbed into the body through the skin.

Functional Uses

Industrial and product-use categories associated with this substance.

SOURCE EPA CPDat 2 records
Dye

NOAEL Studies

Toxicology endpoints rendered from public NOAEL study rows.

SOURCE NOAEL studies Showing 31 of 31 studies
ValueUnitEndpointRouteSpeciesSource
276.7ug/mLCD54, EC200Dermal-NTP_ICE_skin_sensitization
5.42ug/mLCD86, EC150Dermal-NTP_ICE_skin_sensitization
6.8ug/mLCD86, EC150Dermal-NTP_ICE_skin_sensitization
115.49ug/mLCV70Dermal-NTP_ICE_skin_sensitization
490.7ug/mLCV75Dermal-NTP_ICE_skin_sensitization
93.3%Depletion CysDermal-NTP_ICE_skin_sensitization
99.2%Depletion CysDermal-NTP_ICE_skin_sensitization
-%Depletion LysDermal-NTP_ICE_skin_sensitization
5.7%Depletion LysDermal-NTP_ICE_skin_sensitization
46.7%Depletion Lys + CysDermal-NTP_ICE_skin_sensitization
50%Depletion Lys + CysDermal-NTP_ICE_skin_sensitization
11.464uMEC1.5Dermal-NTP_ICE_skin_sensitization
0.4%EC3DermalMouseNTP_ICE_skin_sensitization
0.4%EC3DermalMouseNTP_ICE_skin_sensitization
0.4%EC3DermalMouseNTP_ICE_skin_sensitization
0.4%EC3DermalMouseNTP_ICE_skin_sensitization
786.4uMEC3Dermal-NTP_ICE_skin_sensitization
PV83F3C01QUNIIFDA UNII substance identifier--openFDA substances
PV83F3C01QUNIIFDA UNII substance identifier--openFDA substances
PV83F3C01QUNIIFDA UNII substance identifier--openFDA substances
PV83F3C01QUNIIFDA UNII substance identifier--openFDA substances
3IARC groupIARC carcinogenicity classification--IARC Monographs
3unitlessIARC group--NTP_ICE_cancer
>2000uMIC50Dermal-NTP_ICE_skin_sensitization
4.53ratioImaxDermal-NTP_ICE_skin_sensitization
=1800mg/kg bwLD50oralRat (Male/Female)NTP_ICE_acute_oral
=2100mg/kg bwLD50oralRat (Male)NTP_ICE_acute_oral
=3080mg/kg bwLD50oralRatNTP_ICE_acute_oral
1100ppmTop dose-RatNTP_ICE_cancer
2200ppmTop dose-RatNTP_ICE_cancer
4400ppmTop dose-MouseNTP_ICE_cancer

Showing 31 of 31 studies

REACH Registration

Registration status from the ECHA REACH registered substances database.

SOURCE ECHA (EU) 1 records
StatusNameEC NumberLink
Registered2-nitro-p-phenylenediamine226-164-5ECHA overview →

Australian Status (AICIS)

Australian industrial chemicals inventory status and applicable conditions.

SOURCE AICIS inventory 1 records
Inventory Status
listed

Cosmetic Safety Profile

Same-CAS cosmetic ingredient record for cross-vertical context.

SOURCE CosIng / Ingredients DB
EU Status
prohibited
Max
-
Category
Colorant
View full cosmetic safety profile →

Pharmaceutical Data

Same-CAS pharmaceutical records from drug and bioactivity sources.

SOURCE EMBL-EBI ChEMBL CHEMBL353971
ChEMBL Phase
Not listed
Adverse Events
0
Bioactivity
2
View full pharmaceutical profile →

Frequently Asked Questions

What is the NOAEL for 2-Nitro-1,4-phenylenediamine?

2-Nitro-1,4-phenylenediamine has 31 NOAEL studies in the database. The lowest reported value is 0 % via Dermal. Source: NTP_ICE_skin_sensitization.

Is 2-Nitro-1,4-phenylenediamine a carcinogen according to IARC?

2-Nitro-1,4-phenylenediamine is classified by IARC as Group 3 — not classifiable as to its carcinogenicity to humans (evaluated 1992). Source: IARC Monographs on the Identification of Carcinogenic Hazards to Humans.

Is 2-Nitro-1,4-phenylenediamine used in cosmetics?

Yes, 2-Nitro-1,4-phenylenediamine is also indexed as a cosmetic ingredient under the name 2-Nitro-P-Phenylenediamine. View the full cosmetic safety profile on the ingredient page for detailed safety data, SCCS opinions, and regulatory status.

Where does the safety data for 2-Nitro-1,4-phenylenediamine come from?

Safety data is sourced from EPA ToxValDB, EPA CPDat, AICIS (Australian Industrial Chemicals Introduction Scheme), EPA DSSTox, IARC Monographs, ECHA REACH, ILO/WHO ICSC, CosIng / Ingredients DB, ChEMBL / DailyMed. All data traces to primary regulatory sources and is updated from official government databases.

Does 2-Nitro-1,4-phenylenediamine have different safety status in cosmetics vs industrial chemicals?

2-Nitro-1,4-phenylenediamine is prohibited in EU cosmetics but has active industrial GHS classifications (H315, H317, H319, H335, H302).

Is 2-Nitro-1,4-phenylenediamine used outside industrial chemicals?

2-Nitro-1,4-phenylenediamine also appears in cosmetics, pharmaceutical databases.